Citius Pharmaceuticals, Inc. (CTXR) Earnings
|
Expand Research on CTXR
| Next EPS Date | 5/13/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/13/24 | Q224 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/9/24 | Q124 | N/A | N/A | N/A | N/A | $21.3M | N/A | N/A | N/A | ||
| 2/14/24 | Q124 | -$0.06 | N/A | N/A | N/A | $21.3M | N/A |  | | Details | |
| 12/18/23 | Q423 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 12/13/23 | Q423 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 12/25/23 | Q423 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/14/23  |
Q323 | -$0.06 | -$0.06 | $0.00 | N/A | N/A | N/A | | | Details | |
| 5/11/23 | Q223 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A |
